Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

49.13B

Market cap49.13B

Price-Earnings ratio

18.82

Price-Earnings ratio18.82

Dividend yield

1.79%

Dividend yield1.79%

Average volume

4.76M

Average volume4.76M

High today

$116.59

High today$116.59

Low today

$113.61

Low today$113.61

Open price

$114.80

Open price$114.80

Volume

2.82M

Volume2.82M

52 Week high

$172.23

52 Week high$172.23

52 Week low

$113.29

52 Week low$113.29

Stock Snapshot

The current Zoetis(ZTS) stock price is $116.33, with a market capitalization of 49.13B. The stock trades at a price-to-earnings (P/E) ratio of 18.82 and offers a dividend yield of 1.8%.

As of 2026-03-30, Zoetis(ZTS) stock has fluctuated between $113.61 and $116.59. The current price stands at $116.33, placing the stock +2.4% above today's low and -0.2% off the high.

Zoetis(ZTS) shares are trading with a volume of 2.82M, against a daily average of 4.76M.

In the last year, Zoetis(ZTS) shares hit a 52-week high of $172.23 and a 52-week low of $113.29.

ZTS News

Simply Wall St 5d

How Investors May Respond To Zoetis Pivot Toward High-Value Pet Treatments Amid Fewer Vet Visits

On March 17, 2026, Zoetis CEO and Director Kristin C. Peck presented at the virtual KeyBanc Capital Markets Healthcare Forum, outlining the company’s latest vie...

Simply Wall St 6d

Assessing Zoetis Valuation As Higher Value Pet Treatments Offset Softer Vet Visits

Advertisement Conference spotlight and shifting demand in animal health Zoetis (ZTS) is set to present at the 2026 KeyBanc Capital Markets Healthcare Virtual...

Analyst ratings

61%

of 23 ratings

Buy

60.9%

Hold

39.1%

Sell

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.